Skip to content
value.today

Sprout Pharmaceuticals, Inc.

🇺🇸 Raleigh, North Carolina, USAPharmaceuticalsFounded 2011
Total raised
$89 M
5 rounds on record
Latest round
$50 M
May 2015
First round on record
Mar 2012
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Sprout Pharmaceuticals, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2015$50 MNo. 5$50 to $250 million

Sprout Pharmaceuticals, Inc.: Raise no. 5, May 2015

Investors in this round

5 investors had bought by the notice of Jun 8, 2015: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$50 M of $50 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anne S. Tomalin · Executive Officer · Vice President, Global Regulatory Affairs
  • Cynthia Whitehead · Executive Officer, Director · Director, President and Chief Executive Officer
  • Douglas S. Eckert · Executive Officer, Director · Director, Secretary
  • James S. Pruden · Executive Officer · Vice President, Manufacturing
  • Josephine S. Torrente · Executive Officer · Executive Vice President, Corporate and Regulatory Affairs
  • Matthew S. Petzold · Executive Officer · Chief Financial Officer and Treasurer
  • Rich S. Franco · Executive Officer · Executive Vice President, Strategy
  • Robert S. Whitehead · Executive Officer, Director · Director, Executive Director
  • Anthony S. Wild · Director
  • Braxton Robert Goodrich · Director
  • Michael Robert Ford · Director
  • Richard Robert DeSchutter · Director
  • Trygve Robert Mikkelsen · Director
  • W. Robert Dahl · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Company's executive officers.”

Signed by Matthew Petzold, Chief Financial Officer and Treasurer. Source: SEC Form D, newest notice filed Jun 8, 2015. Read the notice at the SEC.

equitySEC
Jun 2014$4 MNo. 4$2 to $10 million

Sprout Pharmaceuticals, Inc.: Raise no. 4, Jun 2014

Investors in this round

69 investors had bought by the notice of Jul 11, 2014: 69 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $15 M offered; $11 M still to sell
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anne S Tomalin · Executive Officer · Acting Vice President, Global Regulatory Affairs
  • Cynthia S Whitehead · Executive Officer, Director · Director, President and Chief Operating Officer
  • Douglas W. Eckert · Executive Officer, Director · Director and Secretary
  • James S Pruden · Executive Officer · Vice President, Manufacturing
  • Matthew S Petzold · Executive Officer · Chief Financial Officer and Treasurer
  • Robert S Whitehead · Executive Officer, Director · Director, Chief Executive Officer
  • Anthony S Wild · Director
  • Braxton W. Goodrich · Director
  • Michael W. Ford · Director
  • Richard W. DeSchutter · Director
  • Robert W. Dahl · Director
  • Trygve W. Mikkelsen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Company's executive officers.”

Signed by Matthew Petzold, Chief Financial Officer and Treasurer. Source: SEC Form D, newest notice filed Jul 11, 2014. Read the notice at the SEC.

equitySEC
Jun 2013$10 MNo. 3$10 to $50 million

Sprout Pharmaceuticals, Inc.: Raise no. 3, Jun 2013

Investors in this round

88 investors had bought by the notice of Jul 26, 2013: 88 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cynthia S. Whitehead · Executive Officer · Chief Operating Officer
  • Douglas S. Eckert · Executive Officer, Director · Director and Secretary
  • Fred S. Pruden · Executive Officer · Vice President, Manufacturing
  • James Robert Symons · Executive Officer · Vice President, Drug Development
  • Matthew S. Petzold · Executive Officer · Chief Financial Officer and Treasurer
  • Robert S. Whitehead · Executive Officer, Director · Director, President and Chief Executive Officer
  • Anthony Robert Wild · Director
  • Braxton Robert Goodrich · Director
  • Michael Robert Ford · Director
  • Richard Robert DeSchutter · Director
  • Trygve Robert Mikkelsen · Director
  • W. Robert Dahl · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Issuer's executive officers.”

Signed by Matthew Petzold, Chief Financial Officer and Treasurer. Source: SEC Form D and 1 amendment, newest notice filed Jul 26, 2013. Read the notice at the SEC.

equitySEC
Jun 2012$20 MNo. 2$10 to $50 million

Sprout Pharmaceuticals, Inc.: Raise no. 2, Jun 2012

Investors in this round

59 investors had bought by the notice of Jul 11, 2012: 59 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cynthia S. Whitehead · Executive Officer · Chief Operating Officer
  • Douglas S. Eckert · Executive Officer, Director · Director and Secretary
  • Fred S. Pruden · Executive Officer · Vice President, Manufacturing
  • James Robert Symons · Executive Officer · Vice President, Drug Development
  • Matthew S. Petzold · Executive Officer · Chief Financial Officer and Treasurer
  • Robert S. Whitehead · Executive Officer, Director · Director, President and Chief Executive Officer
  • Anthony Robert Wild · Director
  • Braxton Robert Goodrich · Director
  • Michael Robert Ford · Director
  • Richard Robert DeSchutter · Director
  • Trygve Robert Mikkelsen · Director
  • W. Robert Dahl · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Issuer's executive officers.”

Signed by Matthew Petzold, Chief Financial Officer and Treasurer. Source: SEC Form D and 1 amendment, newest notice filed Jul 11, 2012. Read the notice at the SEC.

equitySEC
Mar 2012$5 MNo. 1$2 to $10 million

Sprout Pharmaceuticals, Inc.: Raise no. 1, Mar 2012

Investors in this round

61 investors had bought by the notice of Mar 21, 2012: 61 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cynthia S. Whitehead · Executive Officer · Chief Commercial Officer
  • Douglas S. Eckert · Executive Officer, Director · Director and Secretary
  • Fred S. Pruden · Executive Officer · Vice President, Manufacturing
  • James Robert Symons · Executive Officer · Vice President, Drug Development
  • Matthew S. Petzold · Executive Officer · Chief Financial Officer and Treasurer
  • Robert S. Whitehead · Executive Officer, Director · Director, President and Chief Executive Officer
  • Anthony Robert Wild · Director
  • Braxton Robert Goodrich · Director
  • Michael Robert Ford · Director
  • Richard Robert DeSchutter · Director
  • Trygve Robert Mikkelsen · Director
  • W. Robert Dahl · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Board of Directors of the Issuer may, in its discretion, increase the aggregate offering amount to $6,000,000.”
  • On the use of proceeds: “The Proceeds will be used for working capital purposes, of which a portion will be used to pay the salaries of the Issuer's executive officers.”

Signed by Matthew Petzold, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 21, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Sprout Pharmaceuticals, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2015).

    SEC Form D · Jun 2015

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jun 2015

That is all the official record says: Sprout Pharmaceuticals, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Sprout Pharmaceuticals, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 88 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sprout Pharmaceuticals, Inc.
NameRoleNamed in
Anne S. TomalinVice President, Global Regulatory AffairsJun 2015
Cynthia WhiteheadDirector, President and Chief Executive OfficerJun 2015
Douglas S. EckertDirector, SecretaryJun 2015
James S. PrudenVice President, ManufacturingJun 2015
Josephine S. TorrenteExecutive Vice President, Corporate and Regulatory AffairsJun 2015
Matthew S. PetzoldChief Financial Officer and TreasurerJun 2015
Rich S. FrancoExecutive Vice President, StrategyJun 2015
Robert S. WhiteheadDirector, Executive DirectorJun 2015
Anne S TomalinActing Vice President, Global Regulatory AffairsJul 2014
Cynthia S WhiteheadDirector, President and Chief Operating OfficerJul 2014
Douglas W. EckertDirector and SecretaryJul 2014
James S PrudenVice President, ManufacturingJul 2014
Matthew S PetzoldChief Financial Officer and TreasurerJul 2014
Robert S WhiteheadDirector, Chief Executive OfficerJul 2014
Cynthia S. WhiteheadChief Operating OfficerJul 2013
Fred S. PrudenVice President, ManufacturingJul 2013
James Robert SymonsVice President, Drug DevelopmentJul 2013
Anthony S. WildDirectorJun 2015
Braxton Robert GoodrichDirectorJun 2015
Cynthia WhiteheadDirector, President and Chief Executive OfficerJun 2015
Douglas S. EckertDirector, SecretaryJun 2015
Michael Robert FordDirectorJun 2015
Richard Robert DeSchutterDirectorJun 2015
Robert S. WhiteheadDirector, Executive DirectorJun 2015
Trygve Robert MikkelsenDirectorJun 2015
W. Robert DahlDirectorJun 2015
Anthony S WildDirectorJul 2014
Braxton W. GoodrichDirectorJul 2014
Cynthia S WhiteheadDirector, President and Chief Operating OfficerJul 2014
Douglas W. EckertDirector and SecretaryJul 2014
Michael W. FordDirectorJul 2014
Richard W. DeSchutterDirectorJul 2014
Robert S WhiteheadDirector, Chief Executive OfficerJul 2014
Robert W. DahlDirectorJul 2014
Trygve W. MikkelsenDirectorJul 2014
Anthony Robert WildDirectorJul 2013